Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product

CT-P10 (Truxima™) was recently approved as the world's first rituximab biosimilar product in the European Union (EU) and South Korea. To demonstrate biosimilarity of CT-P10 with the reference medicinal product (RMP), extensive 3-way similarity assessment has been conducted between CT-P10, EU-Ri...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:MAbs
Asıl Yazarlar: Lee, Kyoung Hoon, Lee, Jihun, Bae, Jin Soo, Kim, Yeon Jung, Kang, Hyun Ah, Kim, Sung Hwan, Lee, So Jung, Lim, Ki Jung, Lee, Jung Woo, Jung, Soon Kwan, Chang, Shin Jae
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2018
Konular:
Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916562/
https://ncbi.nlm.nih.gov/pubmed/29469653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1433976
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller